XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements Of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Cash flows from operating activities      
Net Income $ 2,139,000 $ 1,835,000  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 270,000 506,000  
Stock based compensation expense   27,000  
Net amortization and accretion of premiums and discounts on securities 131,000 128,000  
Amortization of debt issuance costs 3,000 2,000  
(Gain) on sales of loans held for sale (1,904,000) (1,774,000)  
Proceeds from sales of loans held for sale 58,513,000 82,424,000  
Origination of loans held for sale (61,497,000) (77,698,000)  
Recovery of loan losses (300,000)   $ (500,000)
Loss on sale of other real estate owned   66,000 87,000
Amortization of intangibles 140,000    
Bank owned life insurance income (113,000) (98,000)  
(Increase) decrease in interest receivable (130,000) 94,000  
(Increase) in other assets (878,000) (65,000)  
Decrease in income taxes receivable 77,000    
Increase in income taxes payable 456,000    
(Decrease) in interest payable (7,000) (21,000)  
Increase in other liabilities 107,000 245,000  
Net cash (used in) provided by operating activities (2,993,000) 5,671,000  
Cash flows from investing activities      
Purchases of securities available-for-sale (68,805,000) (14,543,000)  
Proceeds from maturities, calls and paydowns of securities available-for-sale 3,838,000 1,333,000  
Proceeds from sale of other real estate owned   344,000  
Origination of loans, net of principal collected (12,155,000) (4,617,000)  
Purchases of premises and equipment (53,000) (627,000)  
Net cash (used in) investing activities (77,175,000) (18,110,000)  
Cash flows from financing activities      
Net (decrease) increase in deposits (5,629,000) 36,223,000  
Principal payments on finance lease obligations (88,000) (104,000)  
Principal payments on other borrowings (129,000)    
Repurchase of common stock   (212,000)  
Dividends paid to common stockholders (332,000) (304,000)  
Net cash (used in) provided by financing activities (6,178,000) 35,603,000  
Increase (decrease) in cash and cash equivalents (86,346,000) 23,164,000  
Cash and cash equivalents at beginning of period 183,153,000 100,886,000 100,886,000
Cash and cash equivalents at end of period 96,807,000 124,050,000 183,153,000
Supplemental schedule of noncash investing and financing activities Non cash transactions      
Transfer of loans to other real estate owned   66,000 $ 111,000
Fair value adjustment for securities available-for-sale (13,491,000) (3,439,000)  
Cash transactions      
Cash paid for interest $ 532,000 $ 638,000